{"schema_version":"1","generated_at":"2026-10-30T20:34:20.609Z","data_as_of":null,"url":"https://www.findmykol.com/kol/teena-bhatla","json_url":"https://www.findmykol.com/kol/teena-bhatla/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"teena-bhatla","name":"Teena Bhatla","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1457539900","openalex":"A5036508366"},"summary":"Teena Bhatla is an Oncology physician. OpenAlex indexes 56 publications with 1,390 citations (h-index 20).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":56,"cited_by_count":1390,"h_index":20,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":15,"program_years":{"first":2021,"last":null},"rows_total":23,"shown":3,"withheld":20,"rows":[{"payer":"SOBI, INC","program_year":2025,"amount_usd":143.72,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457539900"},{"payer":"Agios Pharmaceuticals, Inc.","program_year":2025,"amount_usd":60.35,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457539900"},{"payer":"SpringWorks Therapeutics, Inc.","program_year":2025,"amount_usd":29.86,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457539900"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1457539900","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2024024493","status":"verified"},{"title":"Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric <i>NTRK</i> Fusion–Positive Solid Tumors (Children's Oncology Group ADVL1823)","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco-24-01854","status":"verified"},{"title":"Low-risk relapsed acute lymphoblastic leukemia in children and young adults: what have we learnt and what’s next?","year":2024,"journal":"Leukemia & lymphoma/Leukemia and lymphoma","source_url":"https://doi.org/10.1080/10428194.2024.2362408","status":"verified"},{"title":"Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.22.02200","status":"verified"},{"title":"Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.10008","status":"verified"}],"source":"works"},"contact":{"address_1":"160 E 32ND ST","address_2":"SECOND FLOOR","city":"New York","state":"NY","zip":"100166004","phone":"212-263-8400","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1457539900","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":20,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2012-11-12","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}